These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 38813382)

  • 1. Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC).
    Patterson BK; Yogendra R; Guevara-Coto J; Mora-Rodriguez RA; Osgood E; Bream J; Parikh P; Kreimer M; Jeffers D; Rutland C; Kaplan G; Zgoda M
    Front Med (Lausanne); 2024; 11():1375607. PubMed ID: 38813382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC).
    Patterson BK; Yogendra R; Guevara-Coto J; Mora-Rodriguez RA; Osgood E; Bream J; Parikh P; Kreimer M; Jeffers D; Rutland C; Kaplan G; Zgoda M
    Front Med (Lausanne); 2023; 10():1122529. PubMed ID: 36844201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Stiffness and Oxidized LDL Independently Associated With Post-Acute Sequalae of SARS-CoV-2.
    Zisis SN; Durieux JC; Mouchati C; Funderburg N; Ailstock K; Chong M; Labbato D; McComsey GA
    Pathog Immun; 2023; 8(2):1-15. PubMed ID: 38156116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post -acute sequalae of COVID-19 and cardiac outcomes in U. S. military members.
    Mabila S; Patel D; Fan M; Stahlman S; Seliga N; Nowak G; Wells N
    Int J Cardiol Cardiovasc Risk Prev; 2023 Jun; 17():200183. PubMed ID: 36936859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein.
    Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
    Front Immunol; 2023; 14():1275925. PubMed ID: 37691950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.
    Latinovic O; Kuruppu J; Davis C; Le N; Heredia A
    Clin Med Ther; 2009; 1():1497-1510. PubMed ID: 19920876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation.
    Merino JJ; Muñetón-Gomez V; Muñetón-Gómez C; Pérez-Izquierdo MÁ; Loscertales M; Toledano Gasca A
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32024104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
    Karampitsakos T; Sotiropoulou V; Katsaras M; Tsiri P; Georgakopoulou VE; Papanikolaou IC; Bibaki E; Tomos I; Lambiri I; Papaioannou O; Zarkadi E; Antonakis E; Pandi A; Malakounidou E; Sampsonas F; Makrodimitri S; Chrysikos S; Hillas G; Dimakou K; Tzanakis N; Sipsas NV; Antoniou K; Tzouvelekis A
    Front Med (Lausanne); 2023; 10():1194925. PubMed ID: 37122328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: D-dimer trends elaborate the heterogeneity of risk in hospitalized patients with COVID-19: a multi-national case series from different waves.
    Ronderos Botero DM; Omar AMS; Pengo MF; Haider SW; Latif H; Parati G; Pengo V; Cañas Arboleda A; Díaz M; Villaquirán-Torres C; Contreras J; Chilimuri S
    Front Med (Lausanne); 2023; 10():1205719. PubMed ID: 37234241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin.
    Pretorius E; Vlok M; Venter C; Bezuidenhout JA; Laubscher GJ; Steenkamp J; Kell DB
    Cardiovasc Diabetol; 2021 Aug; 20(1):172. PubMed ID: 34425843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Products: A Potential New Hope to Defeat Post-acute Sequelae of COVID-19.
    Zhao S; Abdurehim A; Yuan Y; Yang T; Li C; Zhang Y; Li Y; Sun X; Xie J
    Curr Top Med Chem; 2023; 23(26):2436-2451. PubMed ID: 37644742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating the Spectrum of Two Pediatric COVID-19 Complications: Multi-System Inflammatory Syndrome in Children and Post-Acute Sequelae of SARS-CoV-2 Infection.
    Parzen-Johnson S; Katz BZ
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 infection (PASC) in a Large Academic Medical Center in the US.
    Fritsche LG; Jin W; Admon AJ; Mukherjee B
    medRxiv; 2022 Nov; ():. PubMed ID: 36415469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19.
    Goetzl EJ; Yao PJ; Kapogiannis D
    Am J Med; 2023 Aug; 136(8):824-829. PubMed ID: 37072092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
    Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
    Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence.
    Visvabharathy L; Orban ZS; Koralnik IJ
    Front Med (Lausanne); 2022; 9():1003103. PubMed ID: 36213654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection.
    Lieberman-Blum SS; Fung HB; Bandres JC
    Clin Ther; 2008 Jul; 30(7):1228-50. PubMed ID: 18691983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.